ASKING PRICE: $400,000 (ASSET PURCHASE)
Laboratory Nexus is representing a Texas-based, CLIA-certified diagnostic laboratory specializing in clinical chemistry, immunology, hematology, and molecular testing, including PCR-based infectious disease panels.
The laboratory is fully staffed and operational and offers an opportunity to acquire a turnkey laboratory with established infrastructure, equipment, systems, and experienced personnel in place.
The laboratory is currently CLIA-certified. As part of the transition, existing ownership will assist the buyer with initiating new CLIA certification and other applicable credentialing as needed.
FULLY EQUIPPED • TURNKEY LABORATORY • ASSET PURCHASE
ACQUISITION OVERVIEW
• Purchase Price: $400,000
• Transaction Type: Asset purchase
• Included Assets: Laboratory instrumentation, equipment, furniture, and infrastructure
• Current Business Volume: May be negotiated separately
• Operational Status: Fully operational
• CLIA: Laboratory is currently CLIA-certified; existing ownership will assist with initiating new CLIA certification as needed for the buyer
• Transition Support: Existing ownership will assist with applicable credentialing and operational transition
• Reason for Sale: Owner is diversifying into other business ventures
OPERATIONAL SNAPSHOT
• Staff: 7 employees
• Facility Size: Approximately 2,500 square feet
• Equipment Ownership: Combination of owned and leased instrumentation
• Laboratory Information System: Furnished LIS
KEY INSTRUMENTATION
• Abbott Alinity CI, 2 units — Leased
• Abbott Ruby — Leased
• Sysmex UN3000 — Owned and financed
• Siemens Clinitek Status Plus — Owned
• Bio-Rad Opus 384+96 — Owned
• Abbott Immtox — Owned
• KingFisher Flex Extraction System — Owned
• Agena Biosciences MassARRAY Genotyping System — Owned
• K2 Scientific Refrigeration Units, 6 units — Includes –20°C, –80°C, and 2–8°C units
• Bio-Rad CFX384 Real-Time PCR System — Owned
• Fluidigm Juno NGS and Biomark HD — Owned
LABORATORY HIGHLIGHTS
• Turnkey, fully operational clinical laboratory
• Currently CLIA-certified, with ownership available to assist with initiating new CLIA certification as needed
• High-complexity molecular diagnostics capabilities
• Experienced laboratory staff currently in place
• Extensive molecular, chemistry, hematology, and immunology instrumentation
• Existing ownership available to assist with credentialing and ownership transition
• Suitable for an existing laboratory seeking to expand its geographic footprint or testing capabilities
• Established platform for a new entrant into the clinical laboratory market
• Significantly reduces the cost and timeline associated with building and equipping a laboratory from the ground up
